$VICR

D'Amico Andrew sold $249K of VICR

D'Amico Andrew sold 754 shares of VICOR CORP (VICR) at $330.00 ($0.25M total) on 2026-06-23 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · D'Amico Andrew
Published Jun 24, 2026, 5:41 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 24, 2026, 5:41 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$VICR
Neutral
medium confidence
Mentioned
$VICR
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VICRNeutralLow
01

Why it matters

The newest fact is the specific open-market sale (754 shares at $330) and the post-transaction holding of 0 shares, under a pre-arranged 10b5-1 plan.

02

Market read

Traders may note the confirmation of director selling, but the 10b5-1 structure and modest size suggest limited fundamental read-through.

03

What to watch

The article doesn’t disclose whether other insiders also sold around the same period, nor does it provide context on total director holdings before the plan or any subsequent grants.

Relevance 3/10Novelty 3/10Timing: Filed 2026-06-24; transaction dated 2026-06-23.

Background

This is a SEC Form 4 insider transaction disclosure for ViCOR Corp (VICR).

Company-level read

Ticker impact

$VICRNeutralMedium confidence
Context

ViCOR Corp director Andrew D'Amico sold 754 shares in an open-market transaction at $330/share, leaving 0 shares after sale.

Expected impact

Low near-term impact; any effect is likely muted unless follow-on insider selling accelerates.

Evidence & confidence

The filing is a Form 4 insider transaction with a stated pre-arranged 10b5-1 plan and a small absolute share count relative to typical liquidity, providing confirmation rather than a new fundamental catalyst.

Market effects

Minimal—no sector-wide regulatory, product, or demand signal is disclosed.

None indicated.

None indicated.

Counterpoint

Even with a 10b5-1 plan, repeated director sales can still coincide with private views on valuation or liquidity needs; monitor for clustering of similar filings.

Key entities

  • VICOR CORP

    Company whose director insider sale is disclosed on Form 4.

  • D'Amico Andrew

    Director who sold 754 shares in an open-market transaction under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$MXLHighAI 8/10

MXL vs. VICR: Which Has the Better AI Infrastructure Opportunity?

MaxLinear (MXL) and Vicor (VICR) are positioned to benefit from AI infrastructure growth. MXL reported 55% revenue growth in Q2 2026, driven by optical and electrical interconnects. Vicor focuses on power delivery for AI processors. MXL's AI products, like Keystone and Rushmore, are in high demand, with new products expected to launch in 2027 and 2028.

$VICRMedAI 8/10

Vicor (VICR) Q2 2026 Earnings Call Transcript

Vicor’s Q2 2026 earnings call reported product and royalty revenue of $143.4M, up 26.9% sequentially and 1.6% year over year. Advanced products revenue rose to $94.2M. Net income was $49.8M, GAAP diluted EPS $1.40, and cash was $453.6M. The company guided for nearly 10% Q3 revenue growth and over $600M 2026 revenue, citing capacity increases and licensing assumptions.

$VICRMed

Vicor Corp (VICR) Q2 2026 Earnings Call Highlights: Strong Revenue Growth

Vicor Corp said a new license agreement will bring $5 million quarterly payments in year one and $10 million in year two, with $15 million contributing to Q2 revenue and additional revenue recognition expected in Q3 and subsequent quarters. Management also discussed fab capacity expansion to support a $2.5 billion revenue goal and said backlog growth stems mainly from existing customer demand.

$VICRMed

VICOR CORP (VICR): Results of Operations and Financial Condition

VICOR CORP (VICR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 d115827dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 NEWS RELEASE FINANCIAL NEWS BRIEF July 21, 2026 For Immediate Release Vicor Corporation Reports Results for the Second Quarter Ended June 30, 2026 Andover, Mass., July 21, 2026 (GLOBE NEWSWIRE) — Vicor Corporation (NASDAQ: